| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697690 | Cancer Treatment Reviews | 2017 | 8 Pages |
Abstract
Angiogenesis inhibitors increase the risk of hypertension, arterial thromboembolism, cardiac ischemia and cardiac dysfunction. There was no significant difference in cardiovascular risk between direct VEGF inhibitors and small molecule agents.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Husam Abdel-Qadir, Josee-Lyne Ethier, Douglas S. Lee, Paaladinesh Thavendiranathan, Eitan Amir,